Vitrakvi 50419-0391
Generic: Larotrectinib
Product NDC
50419-0391- Manufacturer
- Bayer Healthcare Pharmaceuticals Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- July 26, 2019
- Listing Expires
- December 31, 2027
- Application
- NDA210861
Need to source Vitrakvi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Larotrectinib | 100 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Kinase Inhibitor [EPC]Tropomyosin Receptor Kinases Inhibitors [MoA]
Packaging Options(1)
60 CAPSULE in 1 BOTTLE (50419-391-01)